- Filed
- Dec 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Nov 28, 2025 | 23.65M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 23.5M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 23.22M sh |
| Shares Diluted restated | Q3 2026 · Oct 31, 2024 | 21.77M sh |
| Shares Diluted restated | Q3 2026 · Oct 31, 2024 | 21.44M sh |
| Capex | Q3 2026 · Oct 31, 2025 | $3.42M |
| Capex | Q3 2026 · Oct 31, 2024 | $10.14M |
| Operating Cash Flow | Q3 2026 · Oct 31, 2025 | −$61.61M |
| Operating Cash Flow | Q3 2026 · Oct 31, 2024 | −$144.27M |
| Long Term Debt | Q3 2026 · Oct 31, 2025 | $321.77M |
| Long Term Debt | Q3 2026 · Jan 31, 2025 | $297.09M |
| Cash And Equivalents | Q3 2026 · Oct 31, 2025 | $180.51M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2025 | $224.57M |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | $38.38M |
| Stockholders Equity | Q3 2026 · Jul 31, 2025 | $70.72M |
| Stockholders Equity | Q3 2026 · Apr 30, 2025 | $118.59M |
| Stockholders Equity | Q3 2026 · Jan 31, 2025 | $137.47M |
| Stockholders Equity | Q3 2026 · Oct 31, 2024 | $180.98M |
| Stockholders Equity | Q3 2026 · Jul 31, 2024 | $230.89M |
| Stockholders Equity | Q3 2026 · Apr 30, 2024 | $277.92M |
| Stockholders Equity | Q3 2026 · Jan 31, 2024 | $327.68M |
| Current Liabilities | Q3 2026 · Oct 31, 2025 | $325.52M |
| Current Liabilities | Q3 2026 · Jan 31, 2025 | $293.75M |
| Total Liabilities | Q3 2026 · Oct 31, 2025 | $809.65M |
| Total Liabilities | Q3 2026 · Jan 31, 2025 | $760.7M |
| Current Assets | Q3 2026 · Oct 31, 2025 | $516.13M |
| Current Assets | Q3 2026 · Jan 31, 2025 | $566.57M |
| Total Assets | Q3 2026 · Oct 31, 2025 | $848.03M |
| Total Assets | Q3 2026 · Jan 31, 2025 | $898.18M |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | −$2.23 |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | −$7.57 |
| Eps Diluted restated | Q3 2026 · Oct 31, 2024 | −$3.56 |
| Eps Diluted restated | Q3 2026 · Oct 31, 2024 | −$10.18 |
| Eps Basic | Q3 2026 · Oct 31, 2025 | −$2.23 |
| Eps Basic | Q3 2026 · Oct 31, 2025 | −$7.57 |
| Eps Basic restated | Q3 2026 · Oct 31, 2024 | −$3.56 |
| Eps Basic restated | Q3 2026 · Oct 31, 2024 | −$10.18 |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $17.65M |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $67.96M |
| Sga Expense | Q3 2026 · Oct 31, 2024 | $17.98M |
| Sga Expense | Q3 2026 · Oct 31, 2024 | $52.79M |
| Rd Expense | Q3 2026 · Oct 31, 2025 | $34.68M |
| Rd Expense | Q3 2026 · Oct 31, 2025 | $104.66M |
| Rd Expense | Q3 2026 · Oct 31, 2024 | $38.3M |
| Rd Expense | Q3 2026 · Oct 31, 2024 | $110.86M |
| Net Income | Q3 2026 · Oct 31, 2025 | −$52.48M |
| Net Income | Q3 2026 · Oct 31, 2025 | −$175.78M |
| Net Income | Q3 2026 · Jul 31, 2025 | −$66.18M |
| Net Income | Q3 2026 · Apr 30, 2025 | −$57.12M |
| Net Income | Q3 2026 · Oct 31, 2024 | −$77.59M |
| Net Income | Q3 2026 · Oct 31, 2024 | −$218.26M |
| Net Income | Q3 2026 · Jul 31, 2024 | −$68.87M |
| Net Income | Q3 2026 · Apr 30, 2024 | −$71.8M |
| Operating Income | Q3 2026 · Oct 31, 2025 | −$44.34M |
| Operating Income | Q3 2026 · Oct 31, 2025 | −$157.15M |
| Operating Income | Q3 2026 · Oct 31, 2024 | −$68.17M |
| Operating Income | Q3 2026 · Oct 31, 2024 | −$198.05M |
| Gross Profit | Q3 2026 · Oct 31, 2025 | $32.49M |
| Gross Profit | Q3 2026 · Oct 31, 2025 | $91.2M |
| Gross Profit | Q3 2026 · Oct 31, 2024 | $22.79M |
| Gross Profit | Q3 2026 · Oct 31, 2024 | $71.98M |
| Revenue | Q3 2026 · Oct 31, 2025 | $105.67M |
| Revenue | Q3 2026 · Oct 31, 2025 | $301.9M |
| Revenue | Q3 2026 · Oct 31, 2024 | $99.61M |
| Revenue | Q3 2026 · Oct 31, 2024 | $315.19M |